What Teva Pharmaceutical Industries Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 11 | 58 |
| Total trades | 15 | 117 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 117 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mignone Roberto | Director | Sep 18 | Open-market sale · S | −367,600 | $39.06 | −$14.4M | 0 |
| Savage Brian | Interim Chief Legal Officer | Sep 18 | Open-market sale · S | −314 | $38.70 | −$12.2K | 8,500 |
| Savage Brian | Interim Chief Legal Officer | Sep 18 | Open-market sale · S | −2,525 | $39.15 | −$98.8K | 8,814 |
| Savage Brian | Interim Chief Legal Officer | Sep 18 | Open-market sale · S | −4,503 | $38.69 | −$174K | 11,339 |
| Savage Brian | Interim Chief Legal Officer | Sep 18 | Exercise / conversion · M | +4,503 | $34.70 | +$156K | 15,842 |
| Weiss Amir | Chief Accounting Officer | Aug 21 | Open-market sale · S | −2,500 | $37.63 | −$94.1K | 13,071 |
| Weiss Amir | Chief Accounting Officer | Aug 21 | Exercise / conversion · M | +2,500 | $19.61 | +$49K | 15,571 |
| Weiss Amir | Chief Accounting Officer | Aug 21 | Open-market sale · S | −6,945 | $37.61 | −$261K | 13,071 |
| Satchi-Fainaro Ronit | Director | Aug 21 | Open-market sale · S | −415 | $37.25 | −$15.5K | 111,986 |
| Lippman Evan | EVP, Business Development | Aug 17 | Open-market sale · S | −18,600 | $36.57 | −$680K | 25,591 |
| Zaks Tal Zvi | Director | Aug 05 | Open-market sale · S | −17 | $34.87 | −$593 | 73,247 |
| Jover Placid | See "Remarks" | Aug 03 | Sale for tax withholding · S | −12,827 | $34.88 | −$447K | 6,774 |
| Jover Placid | See "Remarks" | Aug 03 | Exercise / conversion · M | +12,827 | — | — | 19,601 |
| Hughes Eric A | See "Remarks" | Aug 03 | Sale for tax withholding · S | −25,578 | $34.88 | −$892K | 134,877 |
| Hughes Eric A | See "Remarks" | Aug 03 | Exercise / conversion · M | +52,744 | — | — | 160,455 |
| Shields Matthew | EVP, Global Operations | Jun 18 | Open-market sale · S | −9,989 | $32.19 | −$322K | 0 |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Jun 11 | Open-market sale · S | −106,563 | $34.10 | −$3.63M | 65,621 |
| Mignone Roberto | Director | Jun 05 | Exercise / conversion · M | +14,492 | — | — | 119,807 |
| Elstein Amir | Director | Jun 05 | Exercise / conversion · M | +14,492 | — | — | 2,118,455 |
| Zaks Tal Zvi | Director | Jun 05 | Exercise / conversion · M | +14,492 | — | — | 73,264 |
Loading...